AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: Lim, PZ Tunis, SL Edell, WS Jensik, SE Tohen, M
Citation: Pz. Lim et al., Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines, BIPOL DIS, 3(4), 2001, pp. 165-173

Authors: Frazier, JA Biederman, J Tohen, M Feldman, PD Jacobs, TG Toma, V Rater, MA Tarazi, RA Kim, GS Garfield, SB Sohma, M Gonzalez-Heydrich, J Risser, RC Nowlin, ZM
Citation: Ja. Frazier et al., A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder, J CH AD PSY, 11(3), 2001, pp. 239-250

Authors: Vieta, E Reinares, M Corbella, B Benabarre, A Gilaberte, I Colom, F Martinez-Aran, A Gasto, C Tohen, M
Citation: E. Vieta et al., Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder, J CL PSYCH, 21(5), 2001, pp. 469-473

Authors: Silva, JACE Alvarez, N Mazzotti, G Gattaz, WF Ospina, J Larach, V Starkstein, S Oliva, D Cousins, L Tohen, M Taylor, CC Wang, J Tran, PV
Citation: Jace. Silva et al., Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America, J CL PSYCH, 21(4), 2001, pp. 375-381

Authors: Meehan, K Zhang, F David, S Tohen, M Janicak, P Small, J Koch, K Rizk, R Walker, D Tran, P Breier, A
Citation: K. Meehan et al., A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutelyagitated patients diagnosed with bipolar mania, J CL PSYCH, 21(4), 2001, pp. 389-397

Authors: Gonzalez-Pinto, A Lalaguna, B Mosquera, F de Heredia, JLP Gutierrez, M Ezcurra, J Gilaberte, I Tohen, M
Citation: A. Gonzalez-pinto et al., Use of olanzapine in dysphoric mania, J AFFECT D, 66(2-3), 2001, pp. 247-253

Authors: Tohen, M Zhang, F Taylor, CC Burns, P Zarate, C Sanger, T Tollefson, G
Citation: M. Tohen et al., A meta-analysis of the use of typical antipsychotic agents in bipolar disorder, J AFFECT D, 65(1), 2001, pp. 85-93

Authors: Zarate, CA Tohen, M Fletcher, K
Citation: Ca. Zarate et al., Cycling into depression from a first episode of mania: A case-comparison study, AM J PSYCHI, 158(9), 2001, pp. 1524-1526

Authors: Shelton, RC Tollefson, GD Tohen, M Stahl, S Gannon, KS Jacobs, TG Buras, WR Bymaster, FP Zhang, W Spencer, KA Feldman, PD Meltzer, HY
Citation: Rc. Shelton et al., A novel augmentation strategy for treating resistant major depression, AM J PSYCHI, 158(1), 2001, pp. 131-134

Authors: Chengappa, KNR Tohen, M Levine, J Jacobs, T Thase, ME Sanger, TM Kupfer, DJ
Citation: Knr. Chengappa et al., Response to placebo among bipolar I disorder patients experiencing their first manic episode, BIPOL DIS, 2(4), 2000, pp. 332-335

Authors: Tohen, M Jacobs, TG Feldman, PD
Citation: M. Tohen et al., Onset of action of antipsychotics in the treatment of mania, BIPOL DIS, 2(3), 2000, pp. 261-268

Authors: Tohen, M Bromet, E Murphy, JM Tsuang, MT
Citation: M. Tohen et al., Psychiatric epidemiology, HARV R PSYC, 8(3), 2000, pp. 111-125

Authors: Zarate, CA Tohen, M Land, ML
Citation: Ca. Zarate et al., First-episode schizophreniform disorder: comparisons with first-episode schizophrenia, SCHIZOPHR R, 46(1), 2000, pp. 31-34

Authors: Zarate, CA Tohen, M
Citation: Ca. Zarate et M. Tohen, Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study, J CLIN PSY, 61(1), 2000, pp. 33-38

Authors: Street, JS Tollefson, GD Tohen, M Sanger, TM Clark, WS Gannon, KS Wei, HX
Citation: Js. Street et al., Olanzapine for psychotic conditions in the elderly, PSYCHIAT AN, 30(3), 2000, pp. 191-196

Authors: Zarate, CA Tohen, M Land, M Cavanagh, S
Citation: Ca. Zarate et al., Functional impairment and cognition in bipolar disorder, PSYCHIAT Q, 71(4), 2000, pp. 309-329

Authors: Tohen, M Strakowski, SM Zarate, C Hennen, J Stoll, AL Suppes, T Faedda, GL Cohen, BM Gebre-Medhin, P Baldessarini, RJ
Citation: M. Tohen et al., The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis, BIOL PSYCHI, 48(6), 2000, pp. 467-476

Authors: Tohen, M Jacobs, TG Grundy, SL McElroy, SL Banov, MC Janicak, PG Sanger, T Risser, R Zhang, F Toma, V Francis, J Tollefson, GD Breier, A
Citation: M. Tohen et al., Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study, ARCH G PSYC, 57(9), 2000, pp. 841-849

Authors: Baldessarini, RJ Tohen, M Tondo, L
Citation: Rj. Baldessarini et al., Maintenance treatment in bipolar disorder, ARCH G PSYC, 57(5), 2000, pp. 490-492

Authors: Green, AI Tohen, M Patel, JK Banov, M DuRand, C Berman, I Chang, H Zarate, C Posener, J Lee, H Dawson, R Richards, C Cole, JO Schatzberg, AF
Citation: Ai. Green et al., Clozapine in the treatment of refractory psychotic mania, AM J PSYCHI, 157(6), 2000, pp. 982-986

Authors: Tohen, M Hennen, J Zarate, CM Baldessarini, RJ Strakowski, SM Stoll, AL Faedda, GL Suppes, T Gebre-Medhin, P Cohen, BM
Citation: M. Tohen et al., Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features, AM J PSYCHI, 157(2), 2000, pp. 220-228

Authors: Tohen, M Grundy, S
Citation: M. Tohen et S. Grundy, Management of acute mania, J CLIN PSY, 60, 1999, pp. 31-34

Authors: Zarate, CA Tohen, M Narendran, R Tomassini, EC McDonald, J Sederer, M Madrid, AR
Citation: Ca. Zarate et al., The adverse effect profile and efficacy of divalproex sodium compared withvalproic acid: A pharmacoepidemiology study, J CLIN PSY, 60(4), 1999, pp. 232-236

Authors: Tohen, M
Citation: M. Tohen, Handbook of social functioning in schizophrenia, AM J PSYCHI, 156(8), 1999, pp. 1286-1287

Authors: Tohen, M Sanger, TM McElroy, SL Tollefson, GD Chengappa, R Daniel, DG Petty, F Centorrino, F Wang, R Grundy, SL Greaney, MG Jacobs, TG David, SR Toma, V
Citation: M. Tohen et al., Olanzapine versus placebo in the treatment of acute mania, AM J PSYCHI, 156(5), 1999, pp. 702-709
Risultati: 1-25 | 26-30